Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 21:59:27
Baird Medical Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
0,8036 0,44 0,00 176 127
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiBaird Medical Investment Holdings Ltd
TickerBDMD
Kmenové akcie:Ordinary Shares
RICBDMD.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 31.12.2024 143
Akcie v oběhu k 15.01.2026 36 725 899
MěnaUSD
Kontaktní informace
Ulice18/F, Ovest, 77 Wing Lok Street
MěstoGUANGZHOU
PSČ 
ZeměChina
Kontatní osoba 
Funkce kontaktní osoby 
Telefon862 082 185 926

Business Summary: Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Baird Medical Investment Holdings Ltd revenues decreased 39% to $8M. Net loss totaled $11.3M vs. income of $4.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects China (Mainland) segment loss totaling $10.5M vs. income of $5.1M. Basic Earnings per Share excluding Extraordinary Items decreased from $0.17 to -$0.43.
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Other Financial Vehicles
NAICS1997Other Financial Vehicles
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerHaimei Wu4301.01.2024
Acting Chief Financial OfficerJie Li3801.01.2024
Chief Technology Officer, Deputy General ManagerRongjian Lu5901.01.2024
Chief Administrative Officer, DirectorQuan Qiu3201.01.2024
Quality Assurance Department ManagerJin Xu3701.01.2024
Merchandising Department ManagerWei Xu3501.01.2024
Production Department ManagerJianwei Yuan5701.01.2024